8 Heart Attack Clinical Trials in Anaheim, CA (2026)

Q: Are there heart attack clinical trials in Anaheim?

Yes, there are 8 heart attack clinical trials currently recruiting in Anaheim, CA.

Q: How do I join a clinical trial in Anaheim?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you.

Q: Are clinical trials in Anaheim free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Heart Attack Studies in Anaheim

NCT04649242Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....

Anaheim, CAPHASE32,100 participantsPfizer

View Study Details

NCT05125302Recruiting

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

Migraine is a common neurological disorder typically characterized by attacks of throbbing, moderate to severe headache, often associated with nausea, vomiting, and sensitivity to light and sound. Mig...

Anaheim, CAPHASE31,059 participantsAbbVie

View Study Details

NCT05254743Recruiting

A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants may or may not have already had treatment...

Anaheim, CAPHASE3737 participantsLoxo Oncology, Inc.

View Study Details

NCT04743141Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age)....

Anaheim, CAPHASE3600 participantsPfizer

View Study Details

NCT04546399Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

This phase II trial studies the effect of nivolumab in combination with blinatumomab compared to blinatumomab alone in treating patients with B-cell acute lymphoblastic leukemia (B-ALL) that has come ...

Anaheim, CAPHASE2461 participantsNational Cancer Institute (NCI)

View Study Details

NCT05711394Recruiting

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

A migraine is a moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other sy...

Anaheim, CAPHASE3450 participantsAbbVie

View Study Details

NCT06810505Recruiting

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to...

Anaheim, CAPHASE3420 participantsAbbVie

View Study Details

NCT04269902Recruiting

Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study

This phase III trial compares early treatment with venetoclax and obinutuzumab versus delayed treatment with venetoclax and obinutuzumab in patients with newly diagnosed high-risk chronic lymphocytic ...

Anaheim, CAPHASE3247 participantsNational Cancer Institute (NCI)

View Study Details

About Heart Attack Clinical Trials in Anaheim

A heart attack (myocardial infarction) occurs when blood flow to part of the heart muscle is blocked, usually by a blood clot. It is a medical emergency requiring immediate treatment. Long-term management includes medications, lifestyle changes, and cardiac rehabilitation.

There are currently 8 heart attack clinical trials recruiting participants in Anaheim, CA. These studies are seeking a combined 6,074 participants. Research is being sponsored by Pfizer, AbbVie, Loxo Oncology, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Attack Clinical Trials in Anaheim — FAQ

Are there heart attack clinical trials in Anaheim?

Yes, there are 8 heart attack clinical trials currently recruiting in Anaheim, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Anaheim?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you about next steps.

Are clinical trials in Anaheim free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anaheim studies also compensate for your time and travel.

What heart attack treatments are being tested?

The 8 active trials in Anaheim are testing new therapies including novel drugs, biologics, and treatment approaches for heart attack.

Data updated July 18, 2026 from ClinicalTrials.gov